Skip to main content
Stonvex
Loading…
Home
Markets
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search...
Cmd K
Search...
Cmd K
← Back to rankings
AGEN
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Log in
Get Started
Loading latest news…
52w low +14.8%
AGEN
Agenus Inc.
☁️ News word cloud
Top words across the last 50 articles for this ticker.
agenus
class
nasdaq
action
lawsuit
cancer
investors
securities
botensilimab
balstilimab
2024
combination
about
million
effectiveness
made
false
statements
therapy
misleading